Macquarie Group
STML

Macquarie Group’s Stemline Therapeutics, Inc. STML Stock Holding History

Macquarie Group’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-600
Closed -$9K – 2490
2017
Q4 		$9K Buy
+600
New +$9K ﹤0.01% 2293